Transcriptional changes in porcine skin at 7 days following sulfur mustard and thermal burn injury

Cutaneous and Ocular Toxicology

Volumn 28, Issue 3, 2009, Pages 129-140

  Price, Jennifer A ^a   Rogers, James V ^a   McDougal, James N ^b   Shaw, Morgan Q ^a   Reid, Frances M ^a   Graham, John S ^c  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Microarray; Porcine; Skin; Sulfur mustard; Thermal burn injury; Transcriptional changes

Indexed keywords

CALGRANULIN A; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; COMPLEMENT; CXCL2 CHEMOKINE; CYTOKINE; ENZYME; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GROWTH FACTOR; HEME OXYGENASE 1; MEMBRANE RECEPTOR; MUSTARD GAS; OSTEOPONTIN; PEPTIDASE; PHOSPHOTRANSFERASE; RNA; SOMATOMEDIN C; TENASCIN; THROMBOCYTE FACTOR 4; TRANSCRIPTION FACTOR; UROKINASE; UROKINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BURN; CONTROLLED STUDY; EXPOSURE; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; SKIN TOXICITY; SWINE; WOUND HEALING;

ANIMALS; BURNS; BURNS, CHEMICAL; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; MUSTARD GAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; SKIN; SUS SCROFA; TRANSCRIPTION, GENETIC; WOUND HEALING;

SUIDAE; SUS;

EID: 70350645342     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.1080/15569520903097754     Document Type: Article

References (82)

1. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007; 117(5):1219-1222.
2. Dillman JF III, Hege AI, Phillips CS, Orzolek LD, Sylvester AJ, Bossone C, Henemyre-Harris C, Kiser RC, Choi YW, Schlager JJ, Sabourin CL. Microarray analysis of mouse ear tissue exposed to bis-(2-chloroethyl) sulfide: gene expression profiles correlate with treatment efficacy and an established clinical endpoint. J Pharmacol Exp Ther 2006; 317(1):76-87.
3. Gerecke DR, Chen M, Isukapalli SS, Gordon MK, Chang YC, Tong W, Androulakis IP, Georgopoulos PG. Differential gene expression profiling of mouse skin after sulfur mustard exposure: Extended time response and inhibitor effect. Toxicol Appl Pharmacol 2009; 234(2):156-165.
4. McDougal JN, Garrett CM, Amato CM, Berberich SJ. Effects of brief cutaneous JP-8 jet fuel exposures on time course of gene expression in the epidermis. Toxicol Sci 2007; 95(2):495-510.
5. McDougal JN, Garrett CM. Gene expression and target tissue dose in the rat epidermis after brief JP-8 and JP-8 aromatic and aliphatic component exposures. Toxicol Sci 2007; 97(2):569-581.
6. Price JA, Rogers JV, McDougal JN, Shaw MQ, Reid FM, Kiser RC, Graham JS. Gene expression analysis of bromine-induced burns in porcine skin. Toxicol Lett 2008; 182(1-3):69-78.
7. Rogers JV, Garrett CM, McDougal JN. Gene expression in rat skin induced by irritating chemicals. J Biochem Mol Toxicol 2003; 17(3):123-137.
8. Rogers JV, Choi YW, Kiser RC, Babin MC, Casillas RP, Schlager JJ, Sabourin CL. Microarray analysis of gene expression in murine skin exposed to sulfur mustard. J Biochem Mol Toxicol 2004; 18(6):289-299.
9. Rogers JV, McDougal JN, Price JA, Reid FM, Graham JS. Transcriptional responses associated with sulfur mustard and thermal burns in porcine skin. Cutan Ocul Toxicol 2008; 27(3):135-160.
10. Sabourin CL, Rogers JV, Choi YW, Kiser RC, Casillas RP, Babin MC, Schlager JJ. Time- and dose-dependent analysis of gene expression using microarrays in sulfur mustard-exposed mice. J Biochem Mol Toxicol 2004; 18(6):300-312.
11. Montagna W, Yun JS. The skin of the domestic pig. J Invest Dermatol 1964; 42(Jul):11-21.
12. Hebda PA, Klingbeil CK, Abraham JA, Fiddes JC. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J Invest Dermatol 1990; 95(6):626-631.
13. Dick IP, Scott RC. Pig ear skin as an in-vitro model for human skin permeability. J Pharm Pharmacol 1992; 44(8):640-645.
14. Smith KJ, Casillas R, Graham J, Skelton HG, Stemler F, Hackley BE Jr. Histopathologic features seen with different animal models following cutaneous sulfur mustard exposure. J Dermatol Sci 1997; 14(2):126-135.
15. Graham JS, Reid FM, Smith JR, Stotts RR, Tucker ES, Shumaker SM, Niemuth NA, Janny SJ. A cutaneous full- thickness liquid sulfur mustard burn model in weanling swine: Clinical pathology and urinary excretion of thiodiglycol. J Appl Toxicol 2000; 20(suppl 1):S161-S172.
16. Reid FM, Graham J, Niemuth NA, Singer AW, Janny SJ, Johnson JB. Sulfur mustard-induced skin burns in weanling swine evaluated clinically and histopathologically. J Appl Toxicol 2000; 20 (suppl 1):S153-S160.
17. Rice P, Brown RF, Lam DG, Chilcott RP, Bennett NJ. Dermabrasion-a novel concept in the surgical management of sulphur mustard injuries. Burns 2000; 26(1):34-40.
18. Graham JS, Schomacker KT, Glatter RD, Briscoe CM, Braue EH Jr, Squibb KS. Efficacy of laser debridement with autologous splitthickness skin grafting in promoting improved healing of deep cutaneous sulfur mustard burns. Burns 2002; 28(8):719-730.
19. Graham JS, Reid FM, Niemuth NA, Shumaker SM, Waugh JD. Effects of three anesthetic regimens on bioengineering methods conducted on ventral abdominal skin of weanling swine. Journal of Toxicology Cutaneous and Ocular Toxicology 2004; 23(2):105-118.
20. Sabourin CL, Petrali JP, Casillas RP. Alterations in inflammatory cytokine gene expression in sulfur mustard-exposed mouse skin. J Biochem Mol Toxicol 2000; 14(6):291-302.
21. Schlager JJ, Hart BW. Stress gene activity in HepG2 cells after sulfur mustard exposure. J Appl Toxicol 2000; 20(5):395-405.
22. Sabourin CL, Danne MM, Buxton KL, Casillas RP, Schlager JJ. Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J Biochem Mol Toxicol 2002; 16(6):263-272.
23. Platteborze PL. Effects of sulfur mustard on transcription in human epidermal keratinocytes: Analysis by mRNA differential display. J Appl Toxicol 2003; 23(4):249-254.
24. Sabourin CL, Danne MM, Buxton KL, Rogers JV, Niemuth NA, Blank JA, Babin MC, Casillas RP. Modulation of sulfur mustard-induced inflammation and gene expression by olvanil in the hairless mouse vesicant model. Journal of Toxicology Cutaneous and Ocular Toxicology 2003; 22(3):125-136.
25. Sabourin CL, Rogers JV, Stonerock MK, Niemuth NA, Kiser RC, Casbohm SL, Babin MC, Schlager JJ, Casillas RP. Alterations of gene expression in sulfur mustard-exposed skin topicallytreated with vanilloids. Journal of Toxicology Cutaneous and Ocular Toxicology 2004; 23(4):321-328.
26. Feezor RJ, Paddock HN, Baker HV, Varela JC, Barreda J, Moldawer LL, Schultz GS, Mozingo DW. Temporal patterns of gene expression in murine cutaneous burn wound healing. Physiol Genomics 2004; 16(3):341-348.
27. Spies M, Dasu MR, Svrakic N, Nesic O, Barrow RE, Perez- Polo JR, Herndon DN. Gene expression analysis in burn wounds of rats. Am J Physiol Regul Integr Comp Physiol 2002; 283(4):R918-R930.
28. Tsai S, Cassady JP, Freking BA, Nonneman DJ, Rohrer GA, Piedrahita JA. Annotation of the Affymetrix porcine genome microarray. Anim Genet 2006; 37(4):423-424.
29. Schwacha MG, Nickel E, Daniel T. Burn injury-induced alterations in wound inflammation and healing is associated with suppressed hypoxia inducible factor-1alpha expression. Mol Med 2008; 14(9-10):628-633.
30. Coulombe PA. Wound epithelialization: Accelerating the pace of discovery. J Invest Dermatol 2003; 121(2):219-230.
31. Enoch S, Grey JE, Harding KG. ABC of wound healing. Nonsurgical and drug treatments. BMJ 2006; 332(7546):900-903.
32. Graham JS, Chilcott RP, Rice P, Milner SM, Hurst CG, Maliner BI. Wound healing of cutaneous sulfur mustard injuries: Strategies for the development of improved therapies. J Burns Wounds 2005; 4(Jan 5):e1.
33. Nguyen TT, Gilpin DA, Meyer NA, Herndon DN. Current treatment of severely burned patients. Ann Surg 1996; 223(1):14-25.
34. Wolpe SD, Cerami A. Macrophage inflammatory proteins 1 and 2: Members of a novel superfamily of cytokines. FASEB J 1989; 3(14):2565-2573.
35. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83(3):835-870.
36. Fahey TJ III, Sherry B, Tracey KJ, van DS, Jones WG, Minei JP, Morgello S, Shires GT, Cerami A. Cytokine production in a model of wound healing: The appearance of MIP-1, MIP-2, cachectin/ TNF and IL-1. Cytokine 1990; 2(2):92-99.
37. Schaffner A, Rhyn P, Schoedon G, Schaer DJ. Regulated expression of platelet factor 4 in human monocytes-role of PARs as a quantitatively important monocyte activation pathway. J Leukoc Biol 2005; 78(1):202-209.
38. Yu G, Rux AH, Ma P, Bdeir K, Sachais BS. Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent manner. Blood 2005; 105(9):3545-3551.
39. Nervi B, Link DC, DiPersio JF. Cytokines and hematopoietic stem cell mobilization. J Cell Biochem 2006; 99(3):690-705.
40. Khan A, Greenman J, Archibald SJ. Small molecule CXCR4 chemokine receptor antagonists: Developing drug candidates. Curr Med Chem 2007; 14(21):2257-2277.
41. Florin L, Maas-Szabowski N, Werner S, Szabowski A, Angel P. Increased keratinocyte proliferation by JUN-dependent expression of PTN and SDF-1 in fibroblasts. J Cell Sci 2005; 118 (pt 9):1981-1989.
42. Avniel S, Arik Z, Maly A, Sagie A, Basst HB, Yahana MD, Weiss ID, Pal B, Wald O, Ad-El D, Fujii N, Renzana-Seisdedos F, Jung S, Galun E, Gur E, Peled A. Involvement of the CXCL12/ CXCR4 pathway in the recovery of skin following burns. J Invest Dermatol 2006; 126(2):468-476.
43. Kabashima K, Shiraishi N, Sugita K, Mori T, Onoue A, Kobayashi M, Sakabe J, Yoshiki R, Tamamura H, Fujii N, Inaba K, Tokura Y. CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am J Pathol 2007; 171(4):1249-1257.
44. Zong ZW, Cheng TM, Su YP, Ran XZ, Shen Y, Li N, Ai GP, Dong SW, Xu H. Recruitment of transplanted dermal multipotent stem cells to sites of injury in rats with combined radiation and wound injury by interaction of SDF-1 and CXCR4. Radiat Res 2008; 170(4):444-450.
45. Villablanca EJ, Mora JR. A two-step model for Langerhans cell migration to skin-draining LN. Eur J Immunol 2008; 38(11):2975-2980.
46. Chetty A, Cao GJ, Nielsen HC. Insulin-like growth factor-I signaling mechanisms, type I collagen and alpha smooth muscle actin in human fetal lung fibroblasts. Pediatr Res 2006; 60(4):389-394.
47. Edmondson SR, Thumiger SP, Werther GA, Wraight CJ. Epidermal homeostasis: The role of the growth hormone and insulin-like growth factor systems. Endocr Rev 2003; 24(6):737-764.
48. Beckert S, Haack S, Hierlemann H, Farrahi F, Mayer P, Konigsrainer A, Coerper S. Stimulation of steroid- suppressed cutaneous healing by repeated topical application of IGF-I: Different mechanisms of action based upon the mode of IGF-I delivery. J Surg Res 2007; 139(2):217-221.
49. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995; 16(1):3-34.
50. Ortega S, Ittmann M, Tsang SH, Ehrlich M, Basilico C. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci U S A 1998; 95(10):5672-5677.
51. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev 1997; 18(1):26-45.
52. Komi-Kuramochi A, Kawano M, Oda Y, Asada M, Suzuki M, Oki J, Imamura T. Expression of fibroblast growth factors and their receptors during full-thickness skin wound healing in young and aged mice. J Endocrinol 2005; 186(2):273-289.
53. Giachelli CM, Steitz S. Osteopontin: A versatile regulator of inflammation and biomineralization. Matrix Biol 2000; 19(7):615-622.
54. Murry CE, Giachelli CM, Schwartz SM, Vracko R. Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 1994; 145(6):1450-1462.
55. Koh A, da Silva AP, Bansal AK, Bansal M, Sun C, Lee H, Glogauer M, Sodek J, Zohar R. Role of osteopontin in neutrophil function. Immunology 2007; 122(4):466-475.
56. O'Regan A, Berman JS. Osteopontin: A key cytokine in cell- mediated and granulomatous inflammation. Int J Exp Pathol 2000; 81(6):373-390.
57. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 1998; 101(7):1468-1478.
58. Emani S, Zhang J, Guo L, Guo H, Kuo PC. RNA stability regulates differential expression of the metastasis protein, osteopontin, in hepatocellular cancer. Surgery 2008; 143(6):803-812.
59. Teigelkamp S, Bhardwaj RS, Roth J, Meinardus-Hager G, Karas M, Sorg C. Calcium-dependent complex assembly of the myeloic differentiation proteins MRP-8 and MRP-14. J Biol Chem 1991; 266(20):13462-13467.
60. Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: A novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007; 81(1):28-37.
61. Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, Lee K. S100 proteins in the epidermis. J Invest Dermatol 2004; 123(1):23-33.
62. Gebhardt C, Nemeth J, Angel P, Hess J. S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 2006; 72(11):1622-1631.
63. Passey RJ, Xu K, Hume DA, Geczy CL. S100A8: Emerging functions and regulation. J Leukoc Biol 1999; 66(4):549-556.
64. Merryman-Simpson AE, Wood SH, Fretwell N, Jones PG, McLaren WM, McEwan NA, Clements DN, Carter SD, Ollier WE, Nuttall T. Gene (mRNA) expression in canine atopic dermatitis: Microarray analysis. Vet Dermatol 2008; 19(2):59-66.
65. Thorey IS, Roth J, Regenbogen J, Halle JP, Bittner M, Vogl T, Kaesler S, Bugnon P, Reitmaier B, Durka S, Graf A, Wockner M, Rieger N, Konstantinow A, Wolf E, Goppelt A, Werner S. The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes. J Biol Chem 2001; 276(38):35818-35825.
66. Yui S, Nakatani Y, Mikami M. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull 2003; 26(6):753-760.
67. Boots AM, Verhaert PD, te Poele RJ, Evers S, Coenen-de Roo CJ, Cleven J, Bos ES. Antigens up the nose: Identification of putative biomarkers for nasal tolerance induction functional studies combined with proteomics. J Proteome Res 2004; 3(5):1056-1062.
68. Lo WY, Lai CC, Hua CH, Tsai MH, Huang SY, Tsai CH, Tsai FJ. S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining. J Proteome Res 2007; 6(6):2143-2151.
69. Tamaoki M, Imanaka-Yoshida K, Yokoyama K, Nishioka T, Inada H, Hiroe M, Sakakura T, Yoshida T. Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol 2005; 167(1):71-80.
70. Tran KT, Griffith L, Wells A. Extracellular matrix signaling through growth factor receptors during wound healing. Wound Repair Regen 2004; 12(3):262-268.
71. Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988; 107(6 pt 2):2757-2767.
72. Filsell W, Rudman S, Jenkins G, Green MR. Coordinate upregulation of tenascin C expression with degree of photodamage in human skin. Br J Dermatol 1999; 140(4):592-599.
73. Whitby DJ, Longaker MT, Harrison MR, Adzick NS, Ferguson MW. Rapid epithelialisation of fetal wounds is associated with the early deposition of tenascin. J Cell Sci 1991; 99 (pt 3):583-586.
74. Braungart E, Magdolen V, Degitz K. Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes. J Invest Dermatol 2001; 116(5):778-784.
75. Lund LR, Green KA, Stoop AA, Ploug M, Almholt K, Lilla J, Nielsen BS, Christensen IJ, Craik CS, Werb Z, Dano K, Romer J. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J 2006; 25(12):2686-2697.
76. Maquerlot F, Galiacy S, Malo M, Guignabert C, Lawrence DA, D'ORTHO MP, Barlovatz-Meimon G. Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healing. Am J Pathol 2006; 169(5):1624-1632.
77. Watanabe M, Yano W, Kondo S, Hattori Y, Yamada N, Yanai R, Nishida T. Up-regulation of urokinase-type plasminogen activator in corneal epithelial cells induced by wounding. Invest Ophthalmol Vis Sci 2003; 44(8):3332-3338.
78. Okumura N, Seki T, Ariga T. Cell surface-bound plasminogen regulates hepatocyte proliferation through a uPA-dependent mechanism. Biosci Biotechnol Biochem 2007; 71(6):1542-1549.
79. Yamaguchi Y, Yamada K, Suzuki T, Wu YP, Kita K, Takahashi S, Ichinose M, Suzuki N. Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]- vasopressin (dDAVP). Am J Physiol Endocrinol Metab 2004; 287(5):E970-E976.
80. Hanselmann C, Mauch C, Werner S. Haem oxygenase-1: A novel player in cutaneous wound repair and psoriasis? Biochem J 2001; 353(pt 3):459-466.
81. Pae HO, Ae HY, Chai KY, Chung HT. Heme oxygenase-1 attenuates contact hypersensitivity induced by 2,4-dinitrofluorobenzene in mice. Immunopharmacol Immunotoxicol 2008; 30(2):207-216.
82. Kirino M, Kirino Y, Takeno M, Nagashima Y, Takahashi K, Kobayashi M, Murakami S, Hirasawa T, Ueda A, Aihara M, Ikezawa Z, Ishigatsubo Y. Heme oxygenase 1 attenuates the development of atopic dermatitis-like lesions in mice: Implications for human disease. J Allergy Clin Immunol 2008; 122(2):290-297.